Author

Sofia Held

Åbo Akademi UniversityORCID 0009-0002-1630-2807Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Sofia Held1 paper · Karolinska Institutet

Biology Disciplines

Click to filter author papers

Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1 Approach:wet-lab / biochemical assay· 1

Frequent Co-Authors

Antti A. MäkitieiD· 1 shared Fabian KrautgasseriD· 1 shared Fabien BertillotiD· 1 shared Gautier FollainiD· 1 shared Giorgio ScitaiD· 1 shared H. IrjalaiD· 1 shared Hellyeh HamidiiD· 1 shared Hind AbdoiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCell Biology

Antti A. MäkitieORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Restoring mechanophenotype reverts malignant properties of ECM-enriched vocal fold cancer

Jasmin Kaivola, Karolina Punovuori, Megan R. Chastney, Hind Abdo, Gautier Follain, Mathilde Mathieu, Omkar Joshi, Yekaterina A. Miroshnikova, Fabian Krautgasser, Jasmin Di Franco, James R. W. Conway, Sofia Held, Fabien Bertillot, Jaana Hagström, Antti A. Mäkitie, , Johanna Ivaska

This study shows that restoring mechanophenotype or targeting YAP/TAZ can reverse malignant properties of vocal fold cancer by reducing nuclear YAP and β-catenin levels.

Nature Materials · Feb 20, 2026Peer-reviewedCell Biology